Hj. Thompson et al., COMPARISON OF THE EFFECTS OF AN ORGANIC AND AN INORGANIC FORM OF SELENIUM ON A MAMMARY-CARCINOMA CELL-LINE, Carcinogenesis, 15(2), 1994, pp. 183-186
The development of new compounds,vith greater cancer inhibitory activi
ty and that are well tolerated continues to be a priority in chemoprev
ention research involving selenium. One compound, 1,-4-phenylene-bis(m
ethylene)selenocyanate (p-XSC), is representative of a series of organ
oselenium compounds with these characteristics. Tn this study, the eff
ects of p-XSC on a mouse mammary carcinoma cell line were compared to
those of sodium selenite, which has been shown to be growth inhibitory
. Treatment with p-XSC caused a 3- to 6-fold greater accumulation of s
elenium within cells than did treatment with equivalent amounts of sel
enite and cells were able to better tolerate higher cellular levels of
selenium derived from p-XSC. Both compounds resulted in a dose-depend
ent reduction in cell number after 24 h of exposure. Selenite and p-XS
C also caused a dose-dependent increase in cell death by apoptosis. Th
is effect was observed within 5 h of treatment. The effect of p-XSC on
apoptosis was more pronounced than that of selenite, especially at th
e 20 mu M level of exposure. The induction of apoptosis by selenium co
mpounds may partially account for their chemopreventive activity.